Cathay Cargo has identified a growing market for personalized, door-to-door pharmaceutical shipments, a development anticipated to increase demand for airfreight services. Toby Griffiths, head of cargo global sales & customer solutions at Cathay Cargo, highlighted that this trend is particularly evident in the United States, especially within the cell and gene therapy (CGT) sector.
This evolution in pharmaceutical logistics signifies a move towards more tailored and direct delivery models for sensitive medical products. For freight forwarders and operations managers, this trend suggests a need to enhance capabilities in handling high-value, time-sensitive, and temperature-controlled pharmaceutical cargo. It also implies potential for new service offerings focused on specialized last-mile delivery and stringent cold chain management. Forwarders should anticipate increased demand for dedicated air cargo capacity and specialized handling for these critical shipments, potentially impacting rates for premium pharma lanes.
